What: GLP-1 drugs are reshaping consumer behaviour, driving increased mall traffic and prompting retailers to adapt inventory and wellness offerings.

Why it is important: The intersection of health, technology, and generational change is creating new growth opportunities for malls and apparel retailers.

The growing popularity of GLP-1 drugs, such as Ozempic and Wegovy, is having a profound impact on the retail landscape, particularly in malls and apparel chains. As more consumers turn to these weight-loss medications, retailers are witnessing a notable increase in foot traffic and a shift in demand toward smaller clothing sizes. This trend is compelling brands to rethink their inventory strategies, invest in more agile supply chains, and introduce wellness-oriented product lines to meet evolving customer needs. The influence of these drugs extends beyond apparel, with food and beauty categories also adapting to cater to health-conscious shoppers. At the same time, the resurgence of mall visits, especially among Gen Z consumers, is being fuelled by immersive retail experiences and a focus on community engagement. Retailers and mall operators who successfully integrate health trends, digital innovation, and generational preferences are well-positioned to capture new growth opportunities and secure their relevance in a rapidly changing market.

IADS Notes: In September 2025, Forbes reported on the “Ozempic effect,” noting that the widespread adoption of GLP-1 drugs was driving increased demand for smaller apparel sizes and compelling retailers to overhaul inventory and return strategies to protect margins. By January 2026, Retail Week highlighted Marks & Spencer’s launch of a food range tailored for customers using weight-loss medications, illustrating how retailers are innovating to address health and wellness trends. In February 2026, WWD emphasised that GLP-1 drugs were reshaping US retail by boosting demand for wellness products and prompting operational changes across inventory, food, and beauty categories. The revitalisation of malls was further documented in May 2026 by Fashion Network, which attributed rising foot traffic and sales to Gen Z shoppers and experiential retail strategies. Similarly, Forbes in April 2026 explored how Gen Z-focused brands and immersive experiences were driving higher occupancy and engagement in malls, underscoring the importance of adapting to health, technology, and generational shifts for sustained retail growth.

Can GLP-1 drugs save the mall?